Home Novartis sees Q4 profit rise 72 per cent to $2.1B without charges
 

Keywords :   


Novartis sees Q4 profit rise 72 per cent to $2.1B without charges

2013-01-23 10:10:28| Biotech - Topix.net

The result is 72 per cent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million charge after ending its clinical study into wider uses of the hypertension drug Tekturna.

Tags: without rise charges profit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Universal UK resort to open 365 days a year
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
More »